330 related articles for article (PubMed ID: 11401736)
1. Beta-blockers to reduce mortality in patients with systolic dysfunction: a meta-analysis.
Lee S; Spencer A
J Fam Pract; 2001 Jun; 50(6):499-504. PubMed ID: 11401736
[TBL] [Abstract][Full Text] [Related]
2. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
Tang CH; Wang CC; Chen TH; Hong CY; Sue YM
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790
[TBL] [Abstract][Full Text] [Related]
4. Beta blockers and congestive heart failure.
Movahed A
Am Fam Physician; 2000 Dec; 62(11):2402-4. PubMed ID: 11130228
[No Abstract] [Full Text] [Related]
5. Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality.
Perreault S; de Denus S; White M; White-Guay B; Bouvier M; Dorais M; Dubé MP; Rouleau JL; Tardif JC; Jenna S; Haibe-Kains B; Leduc R; Deblois D
Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):81-90. PubMed ID: 27859924
[TBL] [Abstract][Full Text] [Related]
6. Beta-blocker benefit according to severity of heart failure.
Bouzamondo A; Hulot JS; Sanchez P; Lechat P
Eur J Heart Fail; 2003 Jun; 5(3):281-9. PubMed ID: 12798825
[TBL] [Abstract][Full Text] [Related]
7. Influence of beta-blockers on mortality in chronic heart failure.
Hart SM
Ann Pharmacother; 2000 Dec; 34(12):1440-51. PubMed ID: 11144703
[TBL] [Abstract][Full Text] [Related]
8. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
Metra M; Nodari S; D'Aloia A; Muneretto C; Robertson AD; Bristow MR; Dei Cas L
J Am Coll Cardiol; 2002 Oct; 40(7):1248-58. PubMed ID: 12383572
[TBL] [Abstract][Full Text] [Related]
9. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure.
Fröhlich H; Torres L; Täger T; Schellberg D; Corletto A; Kazmi S; Goode K; Grundtvig M; Hole T; Katus HA; Cleland JGF; Atar D; Clark AL; Agewall S; Frankenstein L
Clin Res Cardiol; 2017 Sep; 106(9):711-721. PubMed ID: 28434020
[TBL] [Abstract][Full Text] [Related]
10. The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF.
Wikstrand J; Wedel H; Castagno D; McMurray JJ
J Intern Med; 2014 Feb; 275(2):134-43. PubMed ID: 24118421
[TBL] [Abstract][Full Text] [Related]
11. The impact of beta-blockade on mortality rates in patients with congestive heart failure.
Goldstein S; Gottlieb SS
J Card Fail; 2000 Jun; 6(2 Suppl 1):15-24. PubMed ID: 10908094
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of effect of beta-blocker therapy on mortality in patients with New York Heart Association class IV chronic congestive heart failure.
Whorlow SL; Krum H
Am J Cardiol; 2000 Oct; 86(8):886-9. PubMed ID: 11024409
[No Abstract] [Full Text] [Related]
13. Beta-blockers in heart failure. The 'new wave' of clinical trials.
Krum H
Drugs; 1999 Aug; 58(2):203-10. PubMed ID: 10473016
[TBL] [Abstract][Full Text] [Related]
14. Beta-blockers for chronic heart failure: surviving longer but feeling better?
Bolger AP; Al-Nasser F
Int J Cardiol; 2003 Nov; 92(1):1-8. PubMed ID: 14602210
[TBL] [Abstract][Full Text] [Related]
15. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
[TBL] [Abstract][Full Text] [Related]
16. Effects of beta-blockers for congestive heart failure in pediatric and congenital heart disease patients: a meta-analysis of published studies.
Cho MJ; Lim RK; Jung Kwak M; Park KH; Kim HY; Kim YM; Lee HD
Minerva Cardioangiol; 2015 Dec; 63(6):495-505. PubMed ID: 25283168
[TBL] [Abstract][Full Text] [Related]
17. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
Torp-Pedersen C; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lutiger B; Metra M; Remme WJ; Scherhag A; Skene A;
Am Heart J; 2005 Feb; 149(2):370-6. PubMed ID: 15846279
[TBL] [Abstract][Full Text] [Related]
18. In heart failure, all beta-blockers are not necessarily equal.
Tang WH; Militello M; Francis GS
Cleve Clin J Med; 2003 Dec; 70(12):1081-7. PubMed ID: 14686687
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol).
DiNicolantonio JJ; Lavie CJ; Fares H; Menezes AR; O'Keefe JH
Am J Cardiol; 2013 Mar; 111(5):765-9. PubMed ID: 23290925
[TBL] [Abstract][Full Text] [Related]
20. β-blockers in stage B: a precursor of heart failure.
Sarraf M; Francis GS
Heart Fail Clin; 2012 Apr; 8(2):237-45. PubMed ID: 22405663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]